Chia, Mark A;
Keane, Pearse A;
(2022)
Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease?
The Lancet
, 399
(10326)
pp. 697-699.
10.1016/S0140-6736(22)00105-2.
Preview |
Text
Keane_Comment_Manuscript - Revised _26Nov21_3.0 - MC comments CLEAN_updated disclosure.pdf Download (120kB) | Preview |
Type: | Article |
---|---|
Title: | Beyond anti-VEGF: can faricimab reduce treatment burden for retinal disease? |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/S0140-6736(22)00105-2 |
Publisher version: | https://doi.org/10.1016/S0140-6736(22)00105-2 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL |
URI: | https://discovery.ucl.ac.uk/id/eprint/10143834 |
Downloads since deposit
284Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
![]() |
View Item |